/PRNewswire/ The Hepatitis B and C Diagnostics Market by Type, Disease Type, and Geography - Forecast and Analysis 2023-2027 report has been published by.
HALIFAX, NS / ACCESSWIRE / March 13, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the receipt of a Canadian patent patent (number 2,949,634) for its new innovative and quantitative test system. This is in addition to the U.S. patent (number 11,353,450) received in 2022. Through this new patent, MedMira.
MedMira, Inc.: Corporate Update on Clinical Evaluation of MedMira's Products finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
MedMira, Inc.: CORRECTION BY SOURCE: Corporate Update on Clinical Evaluation of MedMira's Products finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.